Scarica l'app Stockscreener
9.32
3.62%
-0.35
Dopo l'orario di chiusura:
9.22
-0.10
-1.07%
Precedente Chiudi:
$9.67
Aprire:
$9.66
Volume 24 ore:
997.20K
Relative Volume:
0.92
Capitalizzazione di mercato:
$743.30M
Reddito:
$116.30M
Utile/perdita netta:
$17.73M
Rapporto P/E:
44.38
EPS:
0.21
Flusso di cassa netto:
$20.88M
1 W Prestazione:
-5.09%
1M Prestazione:
-3.32%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$9.1869
$9.79
Intervallo di 1 settimana:
$9.1869
$10.06
Portata 52W:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Nome
Niagen Bioscience Inc
Settore
Industria
Telefono
310-388-6706
Indirizzo
10900 WILSHIRE BLVD, LOS ANGELES
Confronta NAGE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
9.32 | 787.96M | 116.30M | 17.73M | 20.88M | 0.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-08-16 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2019-10-16 | Iniziato | Oppenheimer | Outperform |
| 2019-02-14 | Iniziato | B. Riley FBR | Buy |
| 2017-11-27 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-01-03 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Niagen Bioscience Inc Borsa (NAGE) Ultime notizie
What momentum shifts mean for Niagen Bioscience Inc.Long Setup & Stepwise Entry and Exit Trade Signals - Newser
Chart based exit strategy for Niagen Bioscience Inc.Gap Down & Long-Term Investment Growth Plans - Newser
Is Niagen Bioscience Inc. stock poised for growthCEO Change & Precise Entry and Exit Recommendations - Newser
Is Niagen Bioscience Inc. stock bottoming out2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Applying big data sentiment scoring on Niagen Bioscience Inc.Oil Prices & Target Return Focused Stock Picks - Newser
Is a relief rally coming for Niagen Bioscience Inc. holdersMarket Performance Recap & Real-Time Sentiment Analysis - Newser
Will Niagen Bioscience Inc. bounce back from current supportWeekly Trade Recap & Free Low Drawdown Momentum Trade Ideas - Newser
Real time alert setup for Niagen Bioscience Inc. performanceLayoff News & Safe Entry Point Alerts - Newser
How to use Fibonacci retracement on Niagen Bioscience Inc.2025 Major Catalysts & Capital Efficiency Focused Strategies - Newser
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Buy" from Analysts - MarketBeat
Published on: 2025-09-03 01:58:14 - Newser
Does Niagen Bioscience Inc. show high probability of reboundGold Moves & Smart Swing Trading Techniques - Newser
Will Niagen Bioscience Inc. outperform the marketJuly 2025 Trends & Community Verified Trade Signals - Newser
Is Niagen Bioscience Inc. stock reversal real or fake2025 Price Targets & Technical Pattern Based Buy Signals - Newser
Using economic indicators to assess Niagen Bioscience Inc. potentialJuly 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
Niagen Bioscience Inc. stock chart pattern explainedEarnings Beat & AI Enhanced Execution Alerts - Newser
Multi factor analysis applied to Niagen Bioscience Inc.Trade Entry Summary & Long-Term Safe Return Strategies - Newser
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Intrinsic Value Is Potentially 91% Above Its Share Price - Yahoo Finance
Is it too late to sell Niagen Bioscience Inc.Earnings Miss & Real-Time Sentiment Analysis - Newser
Published on: 2025-09-02 10:16:45 - Newser
Historical volatility pattern of Niagen Bioscience Inc. visualizedWeekly Market Report & Daily Chart Pattern Signal Reports - Newser
Niagen Bioscience Inc. stock momentum explainedQuarterly Profit Summary & Weekly High Return Forecasts - Newser
Wall Street Zen Upgrades Niagen Bioscience (NASDAQ:NAGE) to "Strong-Buy" - MarketBeat
Should you hold or exit Niagen Bioscience Inc. nowJuly 2025 Big Picture & Accurate Intraday Trading Signals - Newser
Key metrics from Niagen Bioscience Inc.’s quarterly dataMarket Risk Summary & Technical Pattern Based Signals - Newser
Is Niagen Bioscience Inc. forming a reversal pattern2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Real time pattern detection on Niagen Bioscience Inc. stockInsider Selling & Stepwise Trade Execution Plans - Newser
How to track smart money flows in Niagen Bioscience Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - Newser
What’s the recovery path for long term holders of Niagen Bioscience Inc.2025 Macro Impact & AI Enhanced Trading Alerts - Newser
Can swing trading help recover from Niagen Bioscience Inc. losses2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
What institutional flow reveals about Niagen Bioscience Inc.2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
Niagen Bioscience Inc Azioni (NAGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Niagen Bioscience Inc Azioni (NAGE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lopez Carlos Luis | SVP, General Counsel |
Mar 07 '25 |
Buy |
7.86 |
273 |
2,146 |
2,251 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Option Exercise |
3.66 |
50,001 |
183,004 |
281,340 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):